Navigation Links
Helix BioPharma Corp. Announces Fiscal Q1 2010 Results
Date:12/9/2009

icology studies.

Operating, general and administration expenses in the first quarter of fiscal 2010 totalled $677,000 (2009 - $1,060,000), for a decrease of $383,000. The reduction in operating, general and administration expenditures is the result of higher costs in the first quarter of fiscal 2009 associated with the filing of a Form 20-F registration statement with the SEC which became effective during the third quarter of fiscal 2009, the implementation of a new financial reporting system which was completed early in the second quarter of fiscal 2009, investor relations initiatives and associated marketing materials and consulting services which have since been terminated.

Amortization of intangible assets in the first quarter of fiscal 2010 totalled $nil (2009 - $3,000). Management determined the carrying value of intangible assets was impaired and wrote down the balance at July 31, 2009. Amortization of capital assets in the first quarter of fiscal 2010 totalled $98,000 (2009 - $64,000).

Stock-based compensation expense in the first quarter of fiscal 2010 totalled $160,000 (2009 - $ nil). The stock-based compensation expense in the first quarter of fiscal 2010 relates to the ongoing amortization of compensation costs of stock options granted on December 17, 2008, over their vesting period.

Interest income in the first quarter of fiscal 2010 totalled $14,000 (2009 - $205,000). The decrease in interest income in fiscal 2010 reflects lower interest rates earned on deposits resulting from the global financial crisis.

Foreign exchange gains in the first quarter of fiscal 2010 totalled $42,000 (2009 - loss of $150,000). Foreign exchange gains are mainly the result of the foreign currency translation of the Company's integrated foreign operation in Ireland. The net assets in Ireland consist mainly of cash and cash equivalents, denominated in Euro dollars, which are used to fund clinical trials of Topical In
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
2. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
3. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
4. Helix BioPharma Corp. Announces Fiscal 2009 Results
5. Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
9. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
10. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)...  SurgiQuest®, Inc. ("SurgiQuest", the "Company"), a leading ... surgery (MIS) announced today that surgeons have successfully ... Adoption has risen rapidly with a 150% growth ... the company,s expansion from robotics into the general ... over 45 countries.   The AirSeal ...
(Date:6/3/2015)... aTyr Pharma, Inc. (NASDAQ: LIFE ), a biotherapeutics company ... address rare diseases, today announced the Company,s participation at the ... be held at the Four Seasons Hotel in ... John Mendlein , aTyr,s CEO and Executive Chairman, is scheduled ... CT on Wednesday, June 10, 2015. The presentation will be ...
(Date:6/3/2015)... , June 3, 2015  GenVec, Inc. (NASDAQ: ... Dr. David T. Curiel and his team ... St. Louis (WUSTL).  Dr. Curiel ... the Cancer Biology Division within the Department of Radiation ... the WUSTL team will create modified versions of GenVec,s ...
Breaking Medicine Technology:Rapid Procedure Growth With SurgiQuest's AirSeal System 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4
... N.Y., Feb. 28, 2011  A 67-year-old man with Alzheimer,s ... after wandering outside in near-freezing temperatures thanks to the quick ... EmSeeQ® wearable locator device. Robert Campbell ... him missing. He was located on Victory Boulevard, more than ...
... Feb. 28, 2011 Goodrich Corporation (NYSE: ... helicopter technology that brings real-time information to air crews ... safety and rescue systems. Heli-Expo 2011 takes place at ... Orlando, Fla.   Goodrich (booth 2142) will ...
Cached Medicine Technology:Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 2Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 3Goodrich to Showcase Advanced Helicopter Systems at Heli-Expo 2
(Date:6/3/2015)... EMBARGOED FOR RELEASE UNTIL 2 P.M. ET, WEDNESDAY, ... of Mother’s Home to Gas Wells , PITTSBURGH, June 3, ... of natural gas wells drilled with hydraulic fracturing were more ... living farther from such wells, according to a University ... southwestern Pennsylvania birth records. , The finding does not ...
(Date:6/3/2015)... Jersey City, NJ (PRWEB) June 03, 2015 ... enterprise collaboration across platforms and devices, announced today that ... Year Award in Collaboration and Content. The company was ... partners for demonstrating excellence in innovation and implementation of ... years winning Microsoft Partner of the Year Awards – ...
(Date:6/3/2015)... ” was featured on NewsWatch as part of its monthly ... applications on the market for iOS, Android, and Windows. Joe ... app review and shared with viewers how this application is ... life. , A common mistake people make with hypnotherapy is ... However, hypnotherapy is intended for anyone who wants to improve ...
(Date:6/3/2015)... WA (PRWEB) June 03, 2015 On June ... the majority of genetic drug sensitivity (pharmacogenetic) testing that it ... to impact as many as 19 million of the 49 ... risk of costly and life-threatening adverse drug events.(1) Sadly, if ... Medicare millions. , Precision Medicine, the use of an individual’s ...
(Date:6/3/2015)... June 03, 2015 Dr. Steven Reisman, a ... Diagnostic Center ( http://www.newyorkcardiac.com ) located in NYC, announced today ... to his practice. In most cases, depending on the level ... day they call, they will be seen by a cardiologist ... as a cardiologist is to ensure that people who have ...
Breaking Medicine News(10 mins):Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 2Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 3Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2
... for Disease Control and Prevention and the American College ... moderate-intensity physical activity on most days of the week ... recommendation is especially important for older Americans, who can ... more at risk for chronic diseases associated with aging. ...
... Perrigo Company (Nasdaq:, PRGO ; TASE) today announced ... and Drug Administration for its Abbreviated New Drug Application ... Perrigo is expecting to begin product shipments to retailers ... The product will be marketed under ...
... chlorine gas disaster in a South Carolina town gives larger ... to prepare emergency response systems for an accidental or terrorist ... available in the January 2009 issue of the American ... of the largest community exposures to chlorine gas since World ...
... abdominal pain of luminal etiology is a challenging problem ... localization of lesion to either small or large bowel ... countries, where most of the population is of low ... small and large bowel lesions simultaneously at a reasonable ...
... Stereotaxis, Inc.,(Nasdaq: STXS ) today announced it ... investors to raise gross proceeds of $20,million through the ... transactions. A portion of the warrants sold will expire ... would provide an additional,approximately $10 million in gross proceeds ...
... to use birth control, study finds , , MONDAY, Dec. ... just as likely to have sex as teens who don,t ... safe sex to prevent disease or pregnancy, a new study ... to delay having sex than non-pledgers," said study author Janet ...
Cached Medicine News:Health News:Another reason to get your hands dirty 2Health News:Perrigo Announces FDA Final Approval for Ibuprofen PM 2Health News:New study examines effects of Graniteville, S.C., chlorine gas disaster 2Health News:New study examines effects of Graniteville, S.C., chlorine gas disaster 3Health News:A new screening test for chronic abdominal pain 2Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 2Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 3Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 4Health News:Many Teens Don't Keep Virginity Pledges 2Health News:Many Teens Don't Keep Virginity Pledges 3
The PowerLab/4ST is a high-performance recording unit with built-in amplifiers and is suitable for physiology teaching. It has been designed to cover the broad experimental requirements in life scien...
... data acquisition system suitable for a wide ... animal physiology, pharmacology, neurophysiology, biology, zoology, biochemistry, ... of recording from very slow to very ... per second continuously to disk), and is ...
Worth 4-Dot Flashlight/Plastic for testing and training of visual functions and testing for fusion, suppression and/or diplopia. Red/green goggle included. Requires 2 C batteries (not included)....
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
Medicine Products: